Showing 1 - 2 results of 2 for search 'Peter A Forsyth', query time: 0.02s Refine Results
  1. 1
    Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.

    Resistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon. by Franz J Zemp, Brienne A McKenzie, Xueqing Lun, Lori Maxwell, Karlyne M Reilly, Grant McFadden, V Wee Yong, Peter A Forsyth

    Published 2013-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study

    Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study by Brian J Czerniecki, Sungjune Kim, Loretta S Loftus, Roberto Díaz, Hatem Soliman, Ricardo L B Costa, Hyo S Han, Younchul Kim, Peter A Forsyth, Kamran A Ahmed, Min Hsuan Wang, Michelle DeJesus, John A Arrington, Aixa E Soyano, Avan J Armaghani, Marilin Rosa, Jimmy J Caudell, Arnold B Etame, Nam D Tran, Hsiang-Hsuan Michael Yu

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: